Drug Development

Gene Therapy Public Health Medical Guidelines Hormones Pharmaceutical Investments Bankruptcy Endocrinology Healthcare Corporate Law Women's Health

19 ARTICLES

2w ago

Novo Nordisk Ends Partnership With Hims & Hers Over Compounded Wegovy Sales

Novo Nordisk cited patient safety concerns in compounded semaglutide sourced from unapproved Chinese suppliers after the FDA declared the GLP-1 shortage over.

9 ARTICLES

3w ago

Bristol Myers Squibb and BioNTech partner on $11 billion bispecific antibody cancer drug

3 ARTICLES

last mo.

Pfizer Secures $6 Billion Licensing Deal for Chinese Cancer Drug SSGJ-707

31 ARTICLES

last mo.

Novo Nordisk CEO Steps Down Following Share Price Collapse

5 ARTICLES

last mo.

GSK Acquires Experimental Liver Drug Efimosfermin for $1.2 Billion Upfront

14 ARTICLES

2mo ago

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

10 ARTICLES

2mo ago

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

4 ARTICLES

2mo ago

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

12 ARTICLES

2mo ago

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

6 ARTICLES

3mo ago

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

4 ARTICLES

3mo ago

Federal Investigation Examines Claims of Pfizer Vaccine Announcement Delay in 2020

4 ARTICLES

3mo ago

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

7 ARTICLES

4mo ago

NHS Approves First Daily Pill for Endometriosis Treatment

4 ARTICLES

4mo ago

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

8 ARTICLES

4mo ago

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

3 ARTICLES

4mo ago

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

3 ARTICLES

4mo ago

FDA to Decide on First Twice-Yearly HIV Prevention Shot by June

Particle.news

Drug Development

Novo Nordisk Ends Partnership With Hims & Hers Over Compounded Wegovy Sales

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion

AstraZeneca Deepens China Pact With $5.2 Billion CSPC Research Collaboration

FDA launches AI assistant Elsa early as staff flag readiness issues

Bristol Myers Squibb and BioNTech partner on $11 billion bispecific antibody cancer drug

Pfizer Secures $6 Billion Licensing Deal for Chinese Cancer Drug SSGJ-707

Novo Nordisk CEO Steps Down Following Share Price Collapse

GSK Acquires Experimental Liver Drug Efimosfermin for $1.2 Billion Upfront

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

Never miss stories about

Drug Development

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

Federal Investigation Examines Claims of Pfizer Vaccine Announcement Delay in 2020

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

NHS Approves First Daily Pill for Endometriosis Treatment

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

FDA to Decide on First Twice-Yearly HIV Prevention Shot by June

Never miss stories about

Drug Development